SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,677 | -66.6% | 896,427 | -27.5% | 0.00% | -75.0% |
| Q2 2023 | $1,608,385 | -1.8% | 1,237,219 | +33.0% | 0.00% | -20.0% |
| Q1 2023 | $1,637,668 | -52.0% | 930,493 | -14.3% | 0.01% | -54.5% |
| Q4 2022 | $3,409,899 | -40.6% | 1,085,955 | -7.3% | 0.01% | -45.0% |
| Q3 2022 | $5,738,000 | +90.2% | 1,170,976 | +60.7% | 0.02% | +100.0% |
| Q2 2022 | $3,017,000 | +44.1% | 728,830 | +102.2% | 0.01% | +66.7% |
| Q1 2022 | $2,094,000 | -42.4% | 360,392 | -25.6% | 0.01% | -25.0% |
| Q4 2021 | $3,633,000 | -8.0% | 484,340 | +10.6% | 0.01% | -11.1% |
| Q3 2021 | $3,947,000 | -38.6% | 438,091 | -18.4% | 0.01% | -40.0% |
| Q2 2021 | $6,426,000 | -44.1% | 536,848 | -41.5% | 0.02% | -50.0% |
| Q1 2021 | $11,499,000 | -41.2% | 917,732 | -26.8% | 0.03% | -46.4% |
| Q4 2020 | $19,571,000 | +16.4% | 1,254,143 | -29.5% | 0.06% | -6.7% |
| Q3 2020 | $16,814,000 | -11.7% | 1,779,310 | -16.3% | 0.06% | -36.2% |
| Q2 2020 | $19,045,000 | +215.4% | 2,125,535 | +124.3% | 0.09% | +91.8% |
| Q1 2020 | $6,038,000 | +53.2% | 947,804 | +101.4% | 0.05% | +308.3% |
| Q4 2019 | $3,940,000 | +171.3% | 470,707 | +193.3% | 0.01% | +140.0% |
| Q3 2019 | $1,452,000 | -4.9% | 160,493 | +99.7% | 0.01% | 0.0% |
| Q1 2018 | $1,527,000 | -52.2% | 80,369 | -58.7% | 0.01% | -50.0% |
| Q4 2017 | $3,193,000 | +1545.9% | 194,719 | +1403.7% | 0.01% | +900.0% |
| Q3 2017 | $194,000 | -84.3% | 12,949 | -90.8% | 0.00% | -75.0% |
| Q2 2017 | $1,234,000 | +507.9% | 140,228 | +530.9% | 0.00% | +300.0% |
| Q4 2015 | $203,000 | -73.6% | 22,226 | -67.9% | 0.00% | -75.0% |
| Q2 2015 | $769,000 | -50.2% | 69,303 | -31.8% | 0.00% | -55.6% |
| Q4 2014 | $1,545,000 | +22.3% | 101,563 | -13.3% | 0.01% | +50.0% |
| Q3 2014 | $1,263,000 | +15.3% | 117,081 | +63.3% | 0.01% | +20.0% |
| Q2 2014 | $1,095,000 | – | 71,688 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,000,000 | $66,540,000 | 6.69% |
| FIC CAPITAL INC | 787,529 | $8,734,000 | 3.47% |
| RA Capital Management | 1,220,209 | $13,532,000 | 1.36% |
| PRINCETON CAPITAL MANAGEMENT INC | 114,120 | $1,266,000 | 0.67% |
| Perceptive Advisors | 800,000 | $8,872,000 | 0.53% |
| Cormorant Asset Management, LP | 361,000 | $4,003,000 | 0.53% |
| Highlander Capital Management, LLC | 43,500 | $482,000 | 0.43% |
| APEX CAPITAL, LLC | 439,900 | $4,878,000 | 0.42% |
| WASATCH ADVISORS LP | 3,091,386 | $34,283,000 | 0.37% |
| Baker Brothers Advisors | 3,230,932 | $35,831,000 | 0.31% |